Category: AHIP

Transparency and High-Value Health Care

As the following examples show, efforts to arm patients with reliable quality and cost data to shop wisely for health care services will have a meaningful impact on bending the current, unsustainable health care cost curve. Continue reading

Posted in: AHIP Studies and Reports, Health Care Costs

Health Plans Leading the Way to Improve Adult Vaccination Rates

Health plans have made improving adult immunization rates a top priority, recognizing that immunizations are one of the best ways to keep patients healthy and reduce the risk of vaccine-preventable deaths and hospitalizations. Continue reading

Posted in: AHIP Studies and Reports, Uncategorized

New issue brief on empowering consumers

Whether it’s a cost calculator or a mobile app, health plans provide consumers with a wide-range of tools that allow individuals to easily compare data on estimated costs of certain procedures and treatments as well as quality measures so they can make informed choices when selecting a provider or hospital. Continue reading

Posted in: AHIP Studies and Reports, Health Care Costs

Stakeholders agree: We need generic competition

Recent proposals to extend market exclusivity for brand-name medications would delay generic competition and have a dangerous effect on pharmaceutical costs – pushing prices higher and higher. Continue reading

Posted in: AHIP Letters, Health Care Costs

Making Quality Measures Work

Developing and aligning quality measures is essential to transitioning from the fee-for-service reimbursement to a health care system that truly rewards value. Continue reading

Posted in: AHIP in the News

New Data Brief on Networks Ensuring Affordable, Accessible Specialty Care

For patients managing complex health conditions, health plans’ networks include a broad range of specialty provider and hospital groups that have a proven track-record of delivering high-quality care, according to a new AHIP data brief. Continue reading

Posted in: AHIP Studies and Reports

New Issue Brief on Specialty Drug Issues and Challenges

A new issue brief from AHIP delves deeper into the challenges posed by high specialty drug pricing, which continues to threaten the availability of affordable coverage options for patients across the country. Continue reading

Posted in: AHIP Studies and Reports, Health Care Costs

Durham Op-Ed: “The Great Threat of Rising Health Care Costs”

Today’s Morning Consult features an op-ed by AHIP Interim CEO Dan Durham, in which he states now is the time to focus on ensuring health care accessibility, affordability, and quality. However, Durham highlights underlying challenges that all stakeholders need to confront in order to move the health system forward. Continue reading

Posted in: AHIP in the News, Cost Alert

Striking down weak patents protects patients

In some cases, explosive drug prices are the result of drugmakers’ patent schemes that financially distress consumers and limit their treatment options. That is why a recent proposal to exempt pharmaceutical companies from a key consumer protection would leave families across the country even more hostage to egregious pharmaceutical prices. Continue reading

Posted in: AHIP Letters, Cost Alert

New Data Brief on Hospital Consolidation and Premiums

The growing body of evidence that hospital consolidation and higher premiums go hand-in-hand has yet another entry. A new AHIP data brief finds that as hospital consolidation increases, so too do premiums. Continue reading

Posted in: AHIP Studies and Reports, Health Care Costs